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We report two cases of descending thoracic aorta floating thrombus treated with Bolton Relay thoracic free-flow stent graft. The
patients had symptoms of lower limb ischemia; they underwent preoperative angiography and CTscan, then we proceeded with
endovascular exclusion of the thrombus from the systemic circulation. At 12 months, the graft was still patent in both patients,
without any signs of endoleak.
1. Introduction
Thoracic aortic mobile mural thrombus (TAMT) is a rare
pathology and a potential source of cerebral, visceral, and
peripheral embolism [1]. As for its rare occurrence, the
literature shows no consensus about its aetiology or its ap-
propriate therapy [2].
We report our experience in endovascular treatment of
aortic thrombi in two cases using endovascular stent graft.
2. Case Reports
A 45-year-old woman was referred to our hospital for an
acute bilateral lower limbs ischemia. Clinical findings showed
ischemic appearance of her distal legs and absence of periph-
eral pulses. She underwent a color-duplex ultrasound exam-
ination which documented thrombosis of both common
femoral arteries, without any signs of atherosclerotic disease,
so we performed an urgent embolectomy. The embolus
macroscopically appeared as a fleshy smooth clot mixed with
fresh portions of blood. Histological examination described
it as fibrinous clot (Figure 1) while immunohistochemical
and tumoral markers’ searches were negative.
Symptoms completely disappeared, but the source of
embolism had to be identified. The patient was not a smoker
and had no history of diabetes nor hypertension. She did
not take any hormone-based medication, and electrocar-
diogram, chest radiography, and coagulation studies were
normal.
Patient’s medical history was negative for cardiovascular
diseases, and a transesophageal echocardiography excluded a
cardiac source of embolism whereas it detected an approxi-
mately 7.5×2.5×1.5 cm intraluminal polypoid floating mass
in the proximal descending thoracic aorta (Figure 2).
Ultrasound patterns of the mass were compatible with
a diagnosis of thrombus, while intimal flaps, tears, or
dissection were excluded. An angio-CT scan confirmed a
free-floating lesion held by a pedicle from the descending
aortic wall close to the isthmus.
A contrast-enhanced MRI was then performed to exclude
an aortic neoplasm. Collaterally, a huge uterine fibroma was
discovered; anticoagulation was gained by heparin infusion
and then followed by LMWH administration, and the patient
underwent preliminary intervention of hysterectomy, in
order to remove the mass which could obstruct our access
to abdominal aorta and iliac arteries.
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Figure 1: Intraoperative (a and b) and histological (c) findings.
Treatment of thoracic thrombus was indicated to prevent
any further embolic acute events, while its aetiology was
still uncertain. Thoracic aorta’s anatomy was favourable
for endovascular coverage of the thrombosis site with a
free-flow stent graft, without interfering with supra-aortic
trunks vasculature so, four weeks later, the patient underwent
endovascular coverage of the thrombus with a Bolton Relay
thoracic free-flow stent graft under general anaesthesia.
After a careful preoperative evaluation of thoracic aorta
and femoral arteries diameters, we chose an aorto-aortic
access below the renal arteries for endograft deliverage
throughout a miniabdominal incisionFrom the left brachial
artery a 5-Fr pigtail flush catheter was used to obtain an
intraoperative aortogram which showed the extension of the
thrombus. Aortography and trans-oesophageal echocardiog-
raphy monitored endograft’s correct delivery.
A 22 mm × 10 cm Bolton Relay free-flow stent-graft was
released in a portion of the aortic arch and descending
aorta, covering the entire thrombus and its implantation
site, to avoid embolism due to squeezing by radial-force and
oversizing.
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Figure 2: Transesophageal echocardiography documenting the
floating mass in descending thoracic aorta.
Postprocedural intrahospital period was free from any
major complications. The patient was discharged 7 days later
on oral lifelong anticoagulation, with an internationalized
ratio between 2 and 3 to prevent any further emboli. At a
followup of 1, 6, 12, 24, and 36 months Angio-CT scans
showed patency of the graft no signs of endoleak (Figure 3);
at clinical examination, there were no signs of neurological
deficits nor signs of limbs ischemia.
A 67-year-old man arrived at our department, with
recurrent feet pain and prostration.
The patient underwent clinical evaluation and laboratory
tests which revealed a moderate renal failure with a creatinine
blood level of 1.93 mg/dL. He was a strong smoker (more
than 30 cigarettes/day) and had a history of medically
well-controlled hypertension. He had dyslipidemia but, he
had no previous history of diabetes; he had a history of
stable angina, but, at the moment he was asymptomatic
and electrocardiogram and chest radiography were normal.
A color-duplex ultrasound evaluation of lower limbs was
negative for obstructions and stenosis of major vessels.
We then performed an Angio-CT scan which excluded
intimal flaps, tears, or dissection, but revealed a floating
mass attached by a small pedicle to the anterior wall of
the proximal thoracic aorta (Figure 4). A contrast-enhanced
MRI excluded an aortic neoplasm and suggested that it could
be a possible thrombus. An endovascular treatment was
indicated to exclude the embolic source, so anticoagulation
therapy was administered to the patient (6000 IU of LMWH
every 12 hours), with a moderate hydratation and Acetyl-
cysteine the day before and the day after the procedure to
prevent any renal damage due to contrast medium.
A Bolton Relay thoracic free-flow stent graft of 34 mm–
100 mm was implanted under general anaesthesia, through-
out a right femoral access for endograft delivery.
A 5-Fr pigtail flush catheter was used to obtain an intra-
operative aortogram which permitted us a safe delivery and
excluded any involvement of the supra-aortic trunk. Once
the femoral artery was isolated, we used a Lunderquist Extra
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Figure 3: Angio-CT scan showing follow-up one year after
intervention.
Stiﬀ (TS c©MG-/-LES) 035/260CM guidewire; the device was
placed to cover the entire thrombus and its implantation
site. Aortography and trans-oesophageal echocardiography
monitored endograft’s correct delivery during the procedure.
During his length of stay, the patient’s immunological
and coagulation studies were normal and a total body CT-
scan excluded any signs of neoplasms.
Procedure and postoperative in-hospital period were free
from any major complications, and creatinine blood level
was 0.87 mg/dL at discharge. The patient left the hospital 7
days after intervention with an oral lifelong anticoagulation
with an internationalized ratio between 2 and 3, to prevent
any further emboli.
During a 2-year follow-up, the patient was still asymp-
tomatic. Serial angio-CT scans performed at 1, 6, and
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Figure 4: Angio-CT documenting the floating thrombus.
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Figure 5: Angio-CT scan two years after endovascular repair.
12 months and thereafter annually after the intervention
documented progressive shrinkage of thrombus between the
aortic inner-lay and the endograft no signs of endoleak. In
Figure 5 a multiplanar curve reconstruction using a Siemens
workstation shows correct apposition of the graft 24 months
after the intervention.
3. Discussion
Arterial embolism in approximately 80% of cases is a
result of heart diseases, but also ulcerated atherosclerotic
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plaques in the aorta and carotid arteries are important
noncardiac sources of emboli. Thrombosis and secondary
embolism can also be associated with cancer, pregnancy, and
hypercoagulation states, and in 10% of patients the source of
peripheral embolism cannot be identified [3].
The first issue was about the identification of the
source of peripheral artery embolism in a young patient
without any signs of atherosclerotic disease nor coagulation
diseases. In our first case, in fact, we performed clinical
examination, laboratory findings, electrocardiography and
finally-angio-CT scan to exclude rare forms such as foreign-
body embolism, septic embolism, embolism from malignant
tissues, embolization from cardiac myxoma or from a
myxomatous atrial septal defect [3].
The second issue concerned the diagnosis of the mass’
aetiology. We suspected an angiosarcoma, a rare disease [4]
which generally grows up from endothelium and develops
intraluminally as a polypoid mass narrowing aortic lumen
[5]; it represents a potential source of emboli and can
cause thrombosis in small vessels after intimal invasion. Its
diagnosis is diﬃcult because it must be diﬀerentiated from
atherosclerosis, dissection or acute aortic syndrome [5], and
thrombus [6]. Angio-CT scan and contrast-enhanced-MRI
are the most sensitive diagnostic methods [5], but also aortic
biopsy with radial-jaw forceps through femoral access and
IVUS-guidance has been described [7]. Moreover, histology
and immunohistochemical markers are useful to confirm the
nature of the mass [6–8]. We excluded also a penetrating aor-
tic ulcer (PAU), which is usually asymptomatic, confined to
the intimal layer, and is associated with a localized dissection.
In our first case, the nature of the mass was confirmed
by a histological sample, while in the second case CT-scan
and MRI preoperative imaging excluded any other kind of
lesions.
We suppose the thrombus in the second case had prob-
ably been caused by atherosclerotic disease due to smoking
history, while in the first case we are still uncertain about its
aetiology; the only finding was a huge uterine fibroids, which,
however, may not be related to the aortic thrombus.
The third issue concerned the choice of the appropriate
therapy. Traditional open repair is justified in well-qualified
units, better when there are no signs of systemic embolism
[1]. Surgical approach includes local thrombectomy or
endarterectomy, aortic segmental resection and prosthesis
substitution [9]. Anticoagulation has been described, too,
in case of small uncomplicated thrombi from coagulation
disorders [10]. Conservative management with only systemic
anticoagulation would however carry significant risks of
embolization, as for the nature of the mass; moreover, there
is no strong evidence as to the duration or success of this
strategy.
In the last decade materials and techniques for endolu-
minal treatment of these thoracic pathologies have improved
[11] and perioperative complication rates seems to be
lower than open approach, even if embolic events during
endovascular procedure are well described [12]. Midterm
results of 24-month followup are encouraging, while long-
term results are still to be discussed. In our first case,
we preferred a less invasive approach rather than an open
approach with extracorporeal circulation, while in the
second case endovascular coverage was chosen for patient’s
comorbidities. As for the choice of the graft, we preferred the
Bolton Relay because we are used to this type of endograft.
Moreover, the presence of a free-flow permitted a good
proximal landing zone without covering the left subclavian
artery.
Finally mobile thrombus of the thoracic aorta is a
rare pathology which needs to be diagnosed as soon as
possible for serious complications that can occur mostly for
embolism. As for its aetiology, diﬀerential diagnosis should
be done with angiosarcoma, aortic dissection, and PAU.
About its treatment, endovascular exclusion of the
floating thrombus is a feasible and less invasive alternative
to open surgery.
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